➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Colorcon
McKinsey
Boehringer Ingelheim
Dow

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

MINITRAN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Minitran

A generic version of MINITRAN was approved as nitroglycerin by AM REGENT on May 24th, 1988.

  Start Trial

Drug patent expirations by year for MINITRAN
Drug Sales Revenue Trends for MINITRAN

See drug sales revenues for MINITRAN

Recent Clinical Trials for MINITRAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Maastricht Radiation OncologyPhase 2
Anticancer Fund, BelgiumPhase 2
Reliable Cancer TherapiesPhase 2

See all MINITRAN clinical trials

Pharmacology for MINITRAN
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for MINITRAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis MINITRAN nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 089773-001 Aug 30, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Valeant Pharms North MINITRAN nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 089772-001 Aug 30, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Valeant Pharms MINITRAN nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 089771-001 Aug 30, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Express Scripts
McKinsey
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.